Routine Depression Screening in an MS Clinic and Its Association with Provider Treatment Recommendations and Related Treatment Outcome

Lara M Stepleman, L. M. Penwell-Waines, Michael John David Rollock, R. S. Casillas, T. Brands, J. Campbell, B. Ange, Jennifer L Waller

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Depression, a frequent concomitant disorder in multiple sclerosis (MS), can impact MS treatment adherence and quality of life. Depression screening in MS care settings may facilitate needed intervention when providers are responsive to screening findings. This study sought to examine the relationship between depression screening results and provider depression treatment recommendations documented in the medical records of 283 patients receiving care in an integrated MS clinic. Forty-six percent of patients screening positive for depression received a treatment recommendation; females, those with past mental health diagnoses, on psychotropic medications, and those with higher symptom severity were more likely to receive a treatment recommendation. On subsequent screenings, patients reported fewer depressive symptoms regardless of whether a formal treatment recommendation was documented. These findings suggest that while depression screening does lead to depression related intervention in many cases, more research is necessary to determine who is most likely to benefit and under what conditions.

Original languageEnglish (US)
Pages (from-to)347-355
Number of pages9
JournalJournal of Clinical Psychology in Medical Settings
Volume21
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Multiple Sclerosis
Depression
Therapeutics
Medical Records
Patient Care
Mental Health
Quality of Life
Research

Keywords

  • Chart review
  • Depression screening
  • Integrated care
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Psychology

Cite this

Routine Depression Screening in an MS Clinic and Its Association with Provider Treatment Recommendations and Related Treatment Outcome. / Stepleman, Lara M; Penwell-Waines, L. M.; Rollock, Michael John David; Casillas, R. S.; Brands, T.; Campbell, J.; Ange, B.; Waller, Jennifer L.

In: Journal of Clinical Psychology in Medical Settings, Vol. 21, No. 4, 01.01.2014, p. 347-355.

Research output: Contribution to journalArticle

@article{a35fd4d8fe604c37b91ff7b4284fec32,
title = "Routine Depression Screening in an MS Clinic and Its Association with Provider Treatment Recommendations and Related Treatment Outcome",
abstract = "Depression, a frequent concomitant disorder in multiple sclerosis (MS), can impact MS treatment adherence and quality of life. Depression screening in MS care settings may facilitate needed intervention when providers are responsive to screening findings. This study sought to examine the relationship between depression screening results and provider depression treatment recommendations documented in the medical records of 283 patients receiving care in an integrated MS clinic. Forty-six percent of patients screening positive for depression received a treatment recommendation; females, those with past mental health diagnoses, on psychotropic medications, and those with higher symptom severity were more likely to receive a treatment recommendation. On subsequent screenings, patients reported fewer depressive symptoms regardless of whether a formal treatment recommendation was documented. These findings suggest that while depression screening does lead to depression related intervention in many cases, more research is necessary to determine who is most likely to benefit and under what conditions.",
keywords = "Chart review, Depression screening, Integrated care, Multiple sclerosis",
author = "Stepleman, {Lara M} and Penwell-Waines, {L. M.} and Rollock, {Michael John David} and Casillas, {R. S.} and T. Brands and J. Campbell and B. Ange and Waller, {Jennifer L}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s10880-014-9409-0",
language = "English (US)",
volume = "21",
pages = "347--355",
journal = "Journal of Clinical Psychology in Medical Settings",
issn = "1068-9583",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Routine Depression Screening in an MS Clinic and Its Association with Provider Treatment Recommendations and Related Treatment Outcome

AU - Stepleman, Lara M

AU - Penwell-Waines, L. M.

AU - Rollock, Michael John David

AU - Casillas, R. S.

AU - Brands, T.

AU - Campbell, J.

AU - Ange, B.

AU - Waller, Jennifer L

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Depression, a frequent concomitant disorder in multiple sclerosis (MS), can impact MS treatment adherence and quality of life. Depression screening in MS care settings may facilitate needed intervention when providers are responsive to screening findings. This study sought to examine the relationship between depression screening results and provider depression treatment recommendations documented in the medical records of 283 patients receiving care in an integrated MS clinic. Forty-six percent of patients screening positive for depression received a treatment recommendation; females, those with past mental health diagnoses, on psychotropic medications, and those with higher symptom severity were more likely to receive a treatment recommendation. On subsequent screenings, patients reported fewer depressive symptoms regardless of whether a formal treatment recommendation was documented. These findings suggest that while depression screening does lead to depression related intervention in many cases, more research is necessary to determine who is most likely to benefit and under what conditions.

AB - Depression, a frequent concomitant disorder in multiple sclerosis (MS), can impact MS treatment adherence and quality of life. Depression screening in MS care settings may facilitate needed intervention when providers are responsive to screening findings. This study sought to examine the relationship between depression screening results and provider depression treatment recommendations documented in the medical records of 283 patients receiving care in an integrated MS clinic. Forty-six percent of patients screening positive for depression received a treatment recommendation; females, those with past mental health diagnoses, on psychotropic medications, and those with higher symptom severity were more likely to receive a treatment recommendation. On subsequent screenings, patients reported fewer depressive symptoms regardless of whether a formal treatment recommendation was documented. These findings suggest that while depression screening does lead to depression related intervention in many cases, more research is necessary to determine who is most likely to benefit and under what conditions.

KW - Chart review

KW - Depression screening

KW - Integrated care

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84919918646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919918646&partnerID=8YFLogxK

U2 - 10.1007/s10880-014-9409-0

DO - 10.1007/s10880-014-9409-0

M3 - Article

VL - 21

SP - 347

EP - 355

JO - Journal of Clinical Psychology in Medical Settings

JF - Journal of Clinical Psychology in Medical Settings

SN - 1068-9583

IS - 4

ER -